Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06NND
|
|||
| Drug Name |
FPA144
|
|||
| Indication | Bladder cancer [ICD-11: 2C94; ICD-9: 188] | Phase 1 | [1] | |
| Gastric adenocarcinoma [ICD-11: 2B72; ICD-9: 151] | Phase 1 | [1] | ||
| Company |
Five Prime Therapeutics South San Francisco, ca
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.